Core Laboratories (NYSE:CLB) Releases Q3 2026 Earnings Guidance

Core Laboratories (NYSE:CLB) updated its third quarter 2026 earnings guidance on Wednesday. The company provided EPS guidance of 0.120-0.200 for the period, compared to the consensus earnings per share estimate of 0.170. The company issued revenue guidance of $128.5 million-$135.5 million, compared to the consensus revenue estimate of $132.5 million.

Analysts Set New Price Targets

Several equities analysts have commented on CLB shares. Weiss Ratings lowered shares of Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. Wall Street Zen cut Core Laboratories from a “hold” rating to a “sell” rating in a research note on Saturday, July 4th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Reduce”.

Core Laboratories Price Performance

NYSE CLB traded down $0.82 during trading on Wednesday, hitting $9.87. 1,604,259 shares of the company’s stock were exchanged, compared to its average volume of 1,134,123. The company has a current ratio of 2.05, a quick ratio of 1.50 and a debt-to-equity ratio of 0.42. The company has a market cap of $454.78 million, a PE ratio of 15.18, a P/E/G ratio of 2.58 and a beta of 1.00. Core Laboratories has a fifty-two week low of $9.72 and a fifty-two week high of $20.36. The stock’s 50 day moving average price is $12.17 and its two-hundred day moving average price is $15.32.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings results on Wednesday, July 29th. The oil and gas company reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.03. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. The company’s quarterly revenue was down 4.3% on a year-over-year basis. During the same period in the prior year, the company posted $0.19 EPS. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. Research analysts expect that Core Laboratories will post 0.53 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Core Laboratories by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company’s stock valued at $418,000 after purchasing an additional 1,170 shares during the period. American Century Companies Inc. lifted its position in shares of Core Laboratories by 14.3% in the 2nd quarter. American Century Companies Inc. now owns 133,033 shares of the oil and gas company’s stock worth $1,533,000 after purchasing an additional 16,677 shares during the period. Quantbot Technologies LP lifted its position in shares of Core Laboratories by 343.7% in the 2nd quarter. Quantbot Technologies LP now owns 17,520 shares of the oil and gas company’s stock worth $202,000 after purchasing an additional 13,571 shares during the period. Sei Investments Co. bought a new stake in shares of Core Laboratories in the 2nd quarter valued at $231,000. Finally, The Manufacturers Life Insurance Company boosted its stake in shares of Core Laboratories by 6.2% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 17,932 shares of the oil and gas company’s stock valued at $207,000 after purchasing an additional 1,040 shares during the last quarter. 97.81% of the stock is currently owned by institutional investors.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.